Biochemical Functions of Coenzyme Q10

Journal of the American College of Nutrition

Volumn 20, Issue 6, 2001, Pages 591-598

  Crane, Frederick L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Antioxidant; Energy coupling; Gene expression; Transmembrane signaling

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; ASCORBIC ACID; CARBOHYDRATE; FATTY ACID; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; PROTON; RADICAL; SIMVASTATIN; THIOL GROUP; TOCOPHEROL; UBIDECARENONE;

AGING; APOPTOSIS; CANCER; CELL FUNCTION; CELL GROWTH; CELL MEMBRANE; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE EXPRESSION; GENE MUTATION; GOLGI COMPLEX; HUMAN; LYSOSOME; MEMBRANE CHANNEL; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PROTON TRANSPORT; REACTION ANALYSIS; REGENERATION; REVIEW; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; BIOCHEMICAL PHENOMENA; HUMANS; UBIQUINONE;

EID: 0035667921     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2001.10719063     Document Type: Article

References (80)

1. Crane FL: New functions for coenzyme Q. Protoplasma, 213: 127-133, 2000.
2. Lenaz G, Faro R, DeBernardo S, Jarreta D, Costa, A, Genova ML, Parenti Castelii G: Location and mobility of coenzyme Q in lipid bilayers and membranes. Biofactors 9: 87-94, 1999.
3. Lopez-Lluch G, Barroso MP, Martin SF, Fernandze-Ayala DJM, Viallaba JM, Navas P: Role of plasma membrane coenzyme Q on the regulation of apoptosis. Biofactors 9: 171-177, 1999.
4. Lenaz G (ed): “Coenzyme Q.” Chichester: Wiley, 1985.
5. Kalen A, Norling B, Appelkvist EL, Dallner G: Ubiquinone biosynthesis by the microsomal fraction of rat liver. Biochim Biophys Acta 926: 70-78, 1987.
6. Cramer WA, Soriano GM: Energy transduction function of the quinone reactions in cytochrome bc complexes. Biofactors 9: 81-86, 1999.
7. Yamamoto Y, Yamashita S: Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. Mol Aspect Med 18(S): 79-84, 1997.
8. Brandt U: Proton translocation in the respiratory chain involving ubiquinone a hypothetical semiquinone switch mechanism for complex I. Biofactors 9: 95-102, 1999.
9. Yu CA, Zhang K-P, Deng H, Xia D, Klm H, Deisenhofer J, Yu L: Structure and reaction mechanisms of the multifunctional mitochondrial cytochrome bc1 complex. Biofactors 9: 103-110, 1999.
10. Gille L, Nohl H,: The existence of a lysosomal redox chain and the role of ubiquinone. Arch Biochem Biophys 375: 347-354, 2000.
11. Basset P: Iron supply and cell growth control. In Crane FL, Morré DJ, Löw H (eds): “Oxidoreduction at the Plasma Membrane 1.” Boca Raton: CRC Press, pp 186-2204, 1990.
12. Crane FL, Sun IL, Crowe, RA, Löw H: Oxidase control of plasma membrane proton transport. In Bittar EE, Bittar N (eds): “Principles of Medical Biology: 4, Cell Chemistry and Physiology, Part III.” Greenwich, CT: JAI Press, pp 169-186, 1996.
13. Crane FL, Sun IL, Crowe R, Löw H: Electron and proton transport across the plasma membrane. J Bioenerg Biomemb 23: 773-803, 1991.
14. Turunen M, Sindelar P, Dallner G: Induction of endogenous coenzyme Q biosynthesis by administration of peroxisomal inducers. Biofactors 9: 131-140, 1999.
15. Takahashi T, Okamoto T, Mori K, Sayo H, Kishi T: Distribution of ubiquinone and ubiquinol homologues in rat tissues and subcellular fraction. Lipids 28: 803-809, 1993.
16. Quinn PJ, Fabisiak JP, Kagan VE: Expansion of the antioxidant function of vitamin E by coenzyme Q. Biofactors 9: 149-154, 1999.
17. Villalba JM, Navas P: Plasma membrane redox system in the control of stress induced apoptosis. Antioxid Redox Signal 2: 213-230, 2000.
18. Takahashi T, Okamoto T, Kishi T: Characterization of NADPH dependent ubiquinone reductase activity in rat liver cytosol. J Biochem 119: 256-263, 1996.
19. Navarro F, Arroyo A, Martin SF, Bello RI, de Cabo R, Burgess JR, Navas P, Villalba JM: Protective role of ubiquinone in vitamin E and selenium deficient plasma membranes. Biofactors 9: 163-170, 1999.
20. Poon WW, Do TQ, Marbois BN, Clarke CF: Sensitivity to treatment with polyunsaturated fatty acids is a general characteristic of the ubiquinone-deficient yeast coq mutants. Mol Aspect Med 18(S): 121-128, 1997.
21. Hoppe U, Bergemann J, Diembech W, Ennen J, Gohla S, Harris I, Jacob J, Kielholz J, Mei W, Pollet D, Schachtschabel D, Suermann G, Schreiner V, Stab F, Steckel F: Coenzyme Q, a cutaneous antioxidant and energizer. Biofactors 9: 371-378, 1999.
22. Arroyo A, Kagan VE, Tyurin VA, Burgess JR, de Cabo R, Navas P, Villalba JM: NADH and NADPH dependent reduction of coenzyme Q at the plasma membrane. Antioxid Redox Signal 2: 251-262, 2000.
23. Thomas SR, Witting PK, Stocker R: A role for reduced coenzyme Q in atherosclerosis. Biofactors 9: 207-224, 1999.
24. Schneider D, Elstner EF: Coenzyme Q10, vitamin E and dihydrothioctic acid cooperatively prevent diene conjugation in isolated low density lipoprotein. Antiox Redox Signal 2: 327-333, 2000.
25. Villalba JM, Crane FL, Navas P: Antioxidative role of ubiquinone in the animal plasma membrane. In Asard H, Berczi A, Caubergs RJ (eds): “Plasma Membrane Redox Systems and their Role in Biological Stress and Disease.” Dordrecht: Kluwer, pp 247-266, 1998.
26. McLennan H, Degli Esposti M: The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomemb 32: 153-162, 2000.
27. Kaltschmidt B, Sparna T, Kaltschmidt C: Activation of NFKB by reactive oxygen intermediates in the nervous system. Antioxid Redox Signal 1: 129-144, 1999.
28. Morad M, Suzuki YJ: Redox regulation of cardiac muscle calcium signaling. Antioxid Redox Signal 2: 65-71, 2000.
29. Eu JP, Surr J, Xu L, Stamler JS, Meissner G: The skeletal muscle calcium release channel: coupled 02 sensor and NO signaling functions. Cell 102: 499-509, 2000.
30. Pessah IN, Feng W: Functional role of hyperreactive sulfhydryl moieties within the ryanodine receptor complex. Antiox Redox Signal 2: 17-25, 2000.
31. Ryser HJ-P, Mandel R, Gallina A, Rivera A: Plasma membrane disulfide isomerase. In Asard H, Berczi A, Caubergs RJ (eds): “Plasma Membrane Redox Systems and their Role in Biological Stress and Disease,” Dordrecht: Kluwer, pp 279-308, 1998
32. Hansford RG, Hogue BA, Mildaziene V: Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomemb 29: 89-95, 1997.
33. Nohl H, Gille L, Schönheit K, Lin Y: Conditions allowing redox cycling ubisemiquinone in mitochondria to establish a direct couple with molecular oxygen. Free Radical Bio Med 20: 207-213, 1996.
34. Crane FL, Sun IL, Barr R, Morré DJ: Coenzyme Q in Golgi apparatus membrane redox activity and proton uptake. In Folkers K, Yamamura Y (eds): “Biomedical and Clinical Aspects of Coenzyme Q,” vol 4. Amsterdam: Elsevier, pp 77-86, 1984.
35. Sun IL, Sun EE, Crane FL, Morré DJ, Lindgren A, Löw H: A requirement for coenzyme Q in plasma membrane electron transport. Proc Nat Acad Sci US 89: 11126-11130, 1992.
36. Ramasarma T, Swaroop A, MacKellar W, Crane FL: Generation of hydrogen peroxide on oxidation of NADH by hepatic plasma membranes. J Bioenerg Biomemb 13: 241-253, 1981.
37. Berridge MV, Tan S: High capacity redox control at the plasma membrane of mammalian cells: Transmembrane, cell surface and serum NADH oxidases. Antioxid Redox Signal 2: 231-242, 2000.
38. Kishi, T, Morré DM, Morré DJ: The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. Biochem Biophys Acta 1412: 66-77, 1999.
39. Alcain FJ, Löw H, Crane FL: Iron at the cell surface controls both DNA synthesis and plasma membrane redox system. Protoplasma 184: 233-237, 1995.
40. Meier B, Jesaitis AJ, Emmendorffer A, Roeslee J, Quinn MT: The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide generating NADPH oxidase systems are structurally and genetically distinct. Biochem J 289: 481-486, 1993.
41. Suh Y-A, Arnold R, Lassegne B, Shi J, Xu X, Sorensen D, Chung AB, Griendling KK, Lambeth JD: Cell transformation by the superoxide generating oxidase Mox-1. Nature 401: 79-82, 1999.
42. Crane FL, Sun IL, Sun EE, Crowe RA: Plasma membrane redox and regulation of cell growth. Protoplasma 184: 3-7, 1995.
43. Sun IL, Crane FL, Chou JY: Modification of transmembrane electron transport activity in plasma membrane of SV 40 transformed pineal cells. Biochim Biophys Acta 886: 327-336 1986.
44. Sun IL, Crane FL: Interactions of antitumor drugs with plasma membranes. In Crane FL, Morré DJ, Löw H (eds): “Oxidoreduction at the Plasma Membrane.” Boca Raton: CRC Press, pp 257-280, 1990.
45. Wenner CE, Cutry AF: The stimulation of cell growth by extracellular oxidants. In Crane FL, Morré DJ, Löw H (eds): “Oxidoreduction at the Plasma Membrane,” Boca Raton: CRC Press, pp 131-139, 1990.
46. Navas P, Sun IL, Morré DJ, Crane FL: Decrease of NADH in HeLa cells in presence of transferrin or ferricyanide. Biochem Biophys Res Commun 133: 110-115, 1986.
47. Fernandez-Ayala DJM, Martin SF, Barroso MP, Gomez-Diaz C, Villalba JM, Rodriguez-Aguilera JC, Lopez-Lluch G, Navas P: Coenzyme Q protects cells against serum withdrawal-induced apoptosis by inhibition of ceramide release and caspase 3 activation. Antioxid Radox Signal 2: 263-276, 2000.
48. Schultz JR, Clarke CF: Functional roles of ubiquinone. In Cardenas E, Packer L (eds): “Mitochondria, Oxidants and Ageing.” New York: M Dekker, pp 95-118, 1999.
49. Rotig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebidean M, Dallner G, Munnich A, Ernster L, Rustin P: Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356: 391-395, 2000.
50. Rosenfeldt FL, Pepe S, Ou R, Mariani JA, Rowland MA, Nagley P, Linnane AW: Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress. Biofactors 9: 291-300, 1999.
51. Willis R, Anthony M, Sun L, House Y, Qiao G: Clinical implications of the correlation between coenzyme Q10 and vitamin B6 status. Biofactors 9: 359-363, 1999.
52. Hodges S, Hertz N, Lockwood K, Lister R: CoQ10: could it have a role in cancer management. Biofactors 9: 365-370, 1999.
53. Beal MF: Coenzyme Q administration and its potential for treatment of neurodegenerative diseases. Biofactors 9: 261-266, 1999.
54. Reahal S, Wriggleworth J: Tissue concentration of coenzyme Q10 in rat following its oral and intraperitoneal administration. Brug Metabol Dispos 20: 423-427, 1992.
55. Nakamura T, Ohno T, Hamamura K, Sato T: Metabolism of coenzyme Q10: biliary and urinary excretion study in guinea pigs. Biofactors 9: 111-120, 1999.
56. Kagan VE, Nohl H, Quinn JP: Coenzyme Q: its role in scavenging and generation of radicals in membranes. In Cardenas E, Packer LM (eds): “Handbook of Antioxidants.” New York: M Dekker, pp 157-201, 1996.
57. Lass A, Kwong L., Sohal RS: Mitochondrial coenzyme Q content and ageing. Biofactors 9: 199-205, 1999.
58. Battino M, Svegliali Baroni S, Littarru GP, Bompadre S, Leone L, Gorini A, Villa RF: Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat. Mol Aspects Med 18(S): 279-282, 1997.
59. Munkholm H, Hansen HHT, Rasmussen K: Coenzyme Q10 treatment in serious heart failure. Biofactors 9: 285-289, 1999.
60. Eriksson JG, Forsen TJ, Mortensen SA, Rohde M: The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors 9: 315-318, 1999.
61. Langsjoen PH, Langsjoen AM: Overview of the use of CoQ10 in cardiovascular disease. Biofactors 9: 273-284, 1999.
62. Poon WW, Barkovich RJ, Hsu AY, Frankel A, Lee PT, Shepherd JN, Myles DC, Clark CF: Yeast and rat Coq 3 and E. coli Ubi G polypeptide both catalyse O-methyltransferase steps in coenzyme Q biosynthesis. J Biol Chem 274: 21665-21672, 1999.
63. Kalen A, Appelkvist E-L, Dallner G: Age related changes in the lipid composition of rat and human tissues. Lipids 24: 579-584, 1989.
64. Mortensen SA, Leth A, Agner E, Rohde M: Dose related decrease of serum CoQ10 during treatment with HMG-CoA reductase inhibitors. Mol Aspect Med 18(S): 137-144, 1997.
65. Bargossi AM, Grossi G, Fiorelia PL, Gaddi A, Guillo R, Battino M: Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by the HMG CoA reductase inhibitors. Mol Aspect Med 15(S): 187-193, 1994.
66. Folkers K, Osterborg A, Nylander M, Morita M, Melistedt H: Activities of vitamin Q in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 234: 296-299, 1997.
67. Gvozdjakova A, Kucharska J, Brannova Z, Kolesar P: Beneficial effect of CoQ10 on the antioxidative status and metabolism of fats and sugars in diabetic patients. Proc First Conference Internat Coenzyme Q10 Assoc, pp. 95-97, 1998.
68. Lester R, Crane FL: The natural occurrence of coenzyme Q and related compounds. J Biol Chem 234: 2169-2175, 1959.
69. Weber C, Bysted A, Holmer G: Coenzyme Q10 in the diet. Daily intake and relative bioavailability. Mol Asp Med 18 (S): 251-254, 1997.
70. Spector DB, Seltzer WK, Goodman SI: Assignment of electron transfer flavoprotein-ubiquinone oxidoreductase (ETFQO) to human chromosome 4q33. Mol Genet Metabol 67: 364-367, 1999.
71. McCady MF: Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics? Med Hypotheses 52: 397-400, 1999.
72. Santos-OcanËαia C, Villalba JM, Cordoba F, Padilia S, Crane FL, Clarke CF, Navas P: Genetic evidence for coenzyme Q in plasma membrane electron transport. J Bioenerg Biomemb 30: 465-472, 1998.
73. Crane FL, Löw H: New functions for coenzyme Q. In Ebadi M, Marwak J, Chopra RK (eds): “Mitochondrial Ubiquinone (Coenzyme Q),” vol. 1. Scottsdale: Prominent Press, pp 183-216, 2001.
74. Rustin P, Munnich A, Rötig A: Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron induced injury in vitro. Biofactors: 247-251, 1999.
75. Sun IL, Nayas P, Crane FL, Morré DJ, Löw H: NADH diferric transferrin reductase activity in liver plasma membranes. J Biol Chem 262: 15915-15921, 1987.
76. Löw H, Crane FL, Partick EJ, Clark MG: Adrenergic stimulation of transsarcolemma electron efflux in perfused rat heart. Possible regulation of Ca channels by a sarcolemma redox system. Biochem Biophys Acta 844: 142-148, 1985.
77. Löw PS, Kiyatkin A, Li Q, Harrison ML: Control of erythrocyte metabolism by redox regulation of tyrosine phosphatases and kinases. Protoplasma 184: 196-202.
78. Gonzalez-Reyes JA, Cordoba F, Navas P: Involvement of plasma membrane redox systems in growth control of animal and plant cells. In Asard H, Berczi A, Canbergs RJ (eds): “Plasma Membrane Redox Systems and their Role in Biological Stress and Disease.” Dordrecht: Kluwer, pp 193-213, 1998.
79. Smith A: Links between cell surface events involving redox active copper and gene regulation in the hemopexin heme transport system. Antioxid Redox Signal 2: 157-175, 2000.
80. Garner B, van Reyk D, Dean R, Jessup W: Direct copper reduction by macrophages. J Biol Chem 272: 6927-6935, 1997.